Syosset, NYCIK 18927704 filings on record
Reported 13F value by quarter
Portfolio value trend — upgrade to see history
UpgradeLargest positions by weight
87 positions · Q4 2025
| # | Security | Shares | Value | % Port. | Δ Shares | Activity |
|---|---|---|---|---|---|---|
| 1 | Calumet Inc | 2.21M | $44.01M | 20.4% | −610.3K | Reduced |
| 2 | Apollo Global Mgmt Inc | 225.0K | $32.57M | 15.1% | 0 | Held |
| 3 | Alphabet Inc | 91.4K | $28.69M | 13.3% | −20.8K | Reduced |
| 4 | Syndax Pharmaceuticals Inc |
| 415.0K |
| $8.72M |
| 4.0% |
| −13.0K |
| Reduced |
| 5 | Xeris Biopharma Holdings Inc | 970.0K | $7.61M | 3.5% | −45.0K | Reduced |
| 6 | Travere Therapeutics Inc | 186.0K | $7.11M | 3.3% | −74.0K | Reduced |
| 7 | Bridgebio Pharma Inc | 85.0K | $6.50M | 3.0% | 0 | Held |
| 8 | Protagonist Therapeutics Inc | 73.0K | $6.38M | 3.0% | −10.0K | Reduced |
| 9 | Jpmorgan Chase & Co. | 19.5K | $6.28M | 2.9% | −897 | Reduced |
| 10 | Janus Detroit Str Tr | 93.5K | $4.73M | 2.2% | −344.2K | Reduced |
See this fund's complete portfolio, full position changes, and activity history.
Unlock full portfolio